I think we are 2 years off from needing to worry about that, and by then the story may be supporting a higher market cap.
I still want to know what they plan to do with the billion dollar drug they shelved after the NDA was denied by the FDA two years ago because of a botched supplier COC issue in one set of over seas trials and the second one they never filed the NDA on (IIRC). They are both sitting on the shelf. $CYTR had one like that they sold to MSTX for a nice bundle of cash and shares, and it is now ANX-188